World Cancer Day 2019
I Am and I Will - you are the hero of this campaign. Start a conversation about cancer today with your family, friends, colleagues and networks.
News
Read the latest news and views from Lymphoma Action.
Use the drop down filter to find the most relevant news for you.
NICE recommends CAR-T cell therapies for lymphoma
New CAR-T cell therapies will be available for selected people with relapsed or refractory large B‑cell lymphoma
Lymphoma Action publish storybook during National Storytelling Week
New edition of Tom has lymphoma now available
Brentuximab vedotin plus chemo better than standard chemo for T-cell lymphoma
Results of the Echelon-2 study show that adding brentuximab vedotin to chemotherapy improves survival in people who have CD30-positive T-cell lymphomas
National study into late effects of Hodgkin lymphoma to double in size
The National Cohort Study researching late effects of Hodgkin lymphoma treatment will be the largest study of its kind in the world
NICE to recommend venetoclax with rituximab for CLL
Venetoclax plus rituximab is now available on the NHS for adults with relapsed or refractory CLL
New treatment for mycosis fungoides or Sézary syndrome (SS)
Mogamulizumab licensed for the treatment of mycosis fungoides or Sézary syndrome (SS)
NICE consultation on brentuximab vedotin
Have your say on brentuximab vedotin for cutaneous T-cell lymphoma
Join the new Lymphoma Community Advisory Board (CAB)
The Lymphoma Coalition Europe (LCE) is looking for people to be members of a new Lymphoma CAB - if you want to influence research and help create a louder voice for the lymphoma community register your interest today.
Jane Slowey memorial membership programme
As part of our commitment to delivering the best possible services for people living with lymphoma, we're delighted that Lymphoma Action will be represented on a new leadership programme for women working in the charity sector.